Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Clinical trials

Clinical trials

24-07-2018 | Rheumatoid arthritis | Article

Clinical, ultrasound, and predictability outcomes following certolizumab pegol treatment (with methotrexate) in patients with moderate-to-severe rheumatoid arthritis: 52-week results from the CZP-SPEED study

Sarzi-Puttini P et al. Adv Ther 2018. doi: 10.1007/s12325-018-0751-8

18-07-2018 | Medications | Article

Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: Open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis

Genovese MC et al. Rheumatology (Oxford) 2018: key173. doi: 10.1093/rheumatology/key173

Similar pharmacokinetics of the adalimumab (Humira®) biosimilar BI 695501 whether administered via subcutaneous autoinjector or prefilled syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, randomized, open-label, parallel-group trials

The authors present two phase 1 studies comparing the pharmacokinetics, safety, and immunogenicity of adalimumab biosimilar BI 695501 delivered via autoinjector versus prefilled syringe [read more].
Ramael S et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0119-1

Similar pharmacokinetics of the adalimumab (Humira®) biosimilar BI 695501 whether administered via subcutaneous autoinjector or prefilled syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, randomized, open-label, parallel-group trials

29-06-2018 | Adalimumab biosimilar | Article

Similar pharmacokinetics of the adalimumab (Humira®) biosimilar BI 695501 whether administered via subcutaneous autoinjector or prefilled syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, randomized, open-label, parallel-group trials

The authors present two phase 1 studies comparing the pharmacokinetics, safety, and immunogenicity of adalimumab biosimilar BI 695501 delivered via autoinjector versus prefilled syringe.

Ramael S et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0119-1

19-06-2018 | Rheumatoid arthritis | Article

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis

Strand V et al. Arthritis Res Ther 2018; 20: 129. doi: 10.1186/s13075-018-1614-z

13-06-2018 | Rheumatoid arthritis | Article

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): A double-blind, randomized controlled phase 3 trial

Genovese MC et al. Lancet 2018. doi: 10.1016/S0140-6736(18)31116-4

11-06-2018 | Rheumatoid arthritis | Article

Tofacitinib, an oral Janus kinase inhibitor: Pooled efficacy and safety analyses in an Australian rheumatoid arthritis population

Hall S et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0118-2

09-06-2018 | Rheumatoid arthritis | Article

The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicenter study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study

Filippou G et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213217

31-05-2018 | Rheumatoid arthritis | Article

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: Results from a prospective randomized controlled study (the second year of the SURPRISE study)

Kaneko Y et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213416

30-05-2018 | Rheumatoid arthritis | Article

The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: Results from the prospective FRAME-cohort study

Rifbjerg-Madsen S et al. Arthritis Res Ther 2018; 20: 105. doi: 10.1186/s13075-018-1581-4

15-05-2018 | Rheumatoid arthritis | Article

Effect of treat-to-target strategies aiming at remission of arterial stiffness in early rheumatoid arthritis: A randomized controlled study

Tam LHP et al. J Rheumatol 2018. doi: 10.3899/jrheum.171128

15-05-2018 | Rheumatoid arthritis | Article

Long-term safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial

Genovese MC et al. J Rheumatol 2018. doi: 10.3899/jrheum.170344

14-05-2018 | Rheumatoid arthritis | Article

Long-term radiographic and patient-reported outcomes in patients with rheumatoid arthritis treated with tofacitinib: ORAL Start and ORAL Scan post-hoc analyses

Strand V et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0113-7

09-05-2018 | Rheumatoid arthritis | Article

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: Safety, efficacy, and radiographic outcomes

Genovese MC et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key121

03-05-2018 | Rheumatoid arthritis | Article

Does psychological stress in patients with clinically suspect arthralgia associate with subclinical inflammation and progression to inflammatory arthritis?

Boer AC et al. Arthritis Res Ther 2018; 20: 93. doi: 10.1186/s13075-018-1587-y

30-04-2018 | Rheumatoid arthritis | Review | Article

Digital health: A new dimension in rheumatology patient care

Kataria S, Ravindran V. Rheumatol Int 2018; Advance online publication. doi: 10.1007/s00296-018-4037-x

25-04-2018 | Rheumatoid arthritis | Article

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: A multinational cross-sectional study

Pappas DA et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4113-3

21-04-2018 | Rheumatoid arthritis | Article

Baricitinib in patients with rheumatoid arthritis and an inadequate response to conventional disease-modifying antirheumatic drugs in United States and rest of world: A subset analysis

Wells AF et al. Rheumatol Ther 2018; 5: 43–55. doi: 10.1007/s40744-018-0110-x

20-04-2018 | Rheumatoid arthritis | Article

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: A secondary analysis of the PRECISION Trial

Solomon DH et al. Rheumatology (Oxford) 2018; Advacne online publication. doi: 10.1093/rheumatology/key105

15-04-2018 | Rheumatoid arthritis | Article

Longterm safety and efficacy of subcutaneous abatacept in patients with rheumatoid arthritis: 5-year results from a phase IIIb trial

Genovese MC et al. J Rheumatol 2018; Advance online publication. doi: 10.3899/jrheum.170344

Next Previous
Image Credits